TY  - GEN
AU  - Stams,Wendy A G
AU  - den Boer,Monique L
AU  - Beverloo,H Berna
AU  - Meijerink,Jules P P
AU  - van Wering,Elisabeth R
AU  - Janka-Schaub,Gritta E
AU  - Pieters,Rob
TI  - Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia
SN  - 1078-0432
PY  - 2005///0829
KW  - Asparaginase
KW  - pharmacology
KW  - Cell Survival
KW  - drug effects
KW  - Child
KW  - Chromosomes, Human, Pair 12
KW  - genetics
KW  - Chromosomes, Human, Pair 21
KW  - Core Binding Factor Alpha 2 Subunit
KW  - DNA-Binding Proteins
KW  - Disease-Free Survival
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Nuclear Proteins
KW  - Oncogene Proteins, Fusion
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Prednisolone
KW  - Proto-Oncogene Proteins
KW  - Proto-Oncogene Proteins c-ets
KW  - RNA, Messenger
KW  - Repressor Proteins
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Transcription Factors
KW  - Translocation, Genetic
KW  - Treatment Outcome
KW  - Vincristine
KW  - ETS Translocation Variant 6 Protein
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-04-1829
ER  -